A PHASE III MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY STUDY TO EVALUATE SAFETY AND EFFICACY OF OCRELIZUMAB IN CHILDREN AND ADOLESCENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS

Public Engagement
Phase III Clinical Trial in pediatric onset MS

Dati Generali

Tipo

03 - Tematica relativa alle scienze della vita e salute

Strutture collegate

Ricerca

Settori


Goal 3: Good health and well-being

Parole chiave libere (2)

OCRELIZUMAB
PEDIATRIC-ONSET MULTIPLE SCLEROSIS
No Results Found

Afferenze

Referenti

TOMASSINI VALENTINA (Organizzatore, Partecipante)

Partecipanti

TOMASSINI VALENTINA (Organizzatore, Partecipante)